Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Discover which cards provide rewards without annual fees. Enjoy benefits while keeping your expenses low.
25,931 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Federal health officials tie lettuce from mexico sold to Taco Bell and other outlets to a cyclospora outbreak spannin...
A little-known Social Security rule could boost monthly benefits for those who have already started collecting. Learn...
Amazon is emerging as an undervalued winner in the AI hyperscaler war, backed by a 30 percent price-performance edge ...
As of mid-February 2026, state regulators hold a steady advantage in the legal battle over prediction markets, even w...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
Markets can tumble fast in crypto, but a disciplined plan can uncover resilient opportunities. This crypto crash play...
Honeywell slashed the price of a $1.92 billion chemicals acquisition by $500 million, a 26% concession tied to softer...
IBM's shares sank as Anthropic's Claude Code intensifies AI competition, pushing ibm’s stock heads worst for a month ...
Amazon disclosed a record $200 billion capital expenditure plan for 2026, prompting investor questions about the time...
Bitcoin edges toward a pivotal support zone as options activity and on-chain data point to renewed downside risk. Coi...
In 2025, rare earths drew intense attention as prices and equities raced higher. The rally cooled quickly, leaving in...